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in the field as a compilation of the data in 1988 and to those who wish to develop
background knowledge as a prelude to reading the current literature.
MARGRETTA R. SEASHORE
Departments ofHuman Genetics andPediatrics
Yale University SchoolofMedicine
GENETICS OF NEUROMUSCULAR DISORDERS. Edited by Christos S. Bartsocas. New
York, Alan R. Liss, Inc., 1989. 216 pp. $48.00.
This book, Volume 306 in the series Progress in Clinical and Biological Research, is
the record of the Fifth Inernational Clinical Genetics Seminar held in Crete, October
1988. Over 60 contributors from all over the world participated in this conference, and
their individual papers comprise thevolume.
Six sections include the following topics: muscular dystrophies, spinal muscular
atrophies, myotonic dystrophy, mitochondrial myopathies, glycogenoses, and a section
which has a potpourri of unclassified neuromuscular disorders. The Aristoteles Com-
memorative Lecture discusses ethical issues in clinical genetics. Some of the papers
constitute reviews of the state of the art in 1988; although the primary information is
published elsewhere, these reviews have been written by prominent experts in those
areas and are thus authoritative. Topics reviewed include "Gene Mapping and the
Muscular Dystrophies" by Peter Harper and "Mitochondrial Encephalomyopathies"
by Salvatore DiMauro. Baraitser presents a short summary of a classification of the
inherited spinal muscular atrophies, which is a useful review. Other papers are reports
of original work and include a report of apparent autosomal dominant inheritance of
adult onset limb-girdle muscular dystrophy in two generations of a single family. The
case report ofmitochondrial disease presenting with glycogen storage is enzymatically
undefined and not too convincing.
Such a symposium must, by its nature, be limited in scope and cannot represent a
complete review of even such a narrow field. Neverthelesss, there are some peculiar
omissions. For example, Harper's review of the mapping of the muscular dystrophy
genes discusses the use of X-autosomal translocations to identify the location of the
DMD gene but fails to mention the importance ofthe X chromosomal deletions in that
mapping story. The review by DiMauro on mitochondrial myopathies fails tocite some
of Wallace's important work in identifying and elucidating several of the mitochon-
drial genedisorders. Nevertheless, this bookprovides a compilation ofgenetic informa-
tion on a selection of inherited neuromuscular disorders ofclinical importance. While
this symposium will be a useful reference for the neurologist and theclinical geneticist,
further reading will be necessary to acquire comprehensive details.
MARGRETTA R. SEASHORE
Departments ofHuman Genetics andPediatrics
Yale University SchoolofMedicine
TREATMENT OF CARDIAC EMERGENCIES. Fifth Edition. By Emanual Goldberger. St.
Louis, MO, The C.V. Mosby Conpany, 1990. 429 pp. No price. Paperbound.
Texts that run to many editions present special problems to reviewers who must deal
with the implication that such books must be very good. Why else is there an nthBOOK REVIEWS
edition? (I'm sure this point has not escaped the attention of publishers.) The
implication ofquality is often valid but not always, and not in Goldberger's Treatment
ofCardiac Emergencies.
The preface does not define the audience for which the book was intended, but
alludes-as in previous editions-to added materials on syndromes, apparatus, drugs,
and updated references. The book is clearly not designed for cardiologists, nor does it
serve the rest of us who must depend on clear and consistent guidelines to be able to
treat cardiac emergencies in an effective-to say nothing of a legally and ethically
acceptable-manner.
Paradoxically, most true cardiac emergencies are treated not by cardiologists but by
emergency department physicians, critical care unit nurses, paramedics, and the like.
Often by the time the cardiologist is involved, the patient is either stabilized or dead.
This fact is why the American Heart Association (AHA) has expended such effort on
the development of Advanced Cardiac Life Support (ACLS) standards and effective
means ofteaching these standards to qualified health care providers. Incidentally, the
AHA textbook on ACLS is a superb manual on diagnosis and management ofcardiac
emergencies and should be a well-worn prime and primary manual for non-
cardiologists.
Any text that is not consistent with ACLS standards is in trouble. It is unacceptable
to read in 1990 that the approach to the unconscious patient is:
1. Immediately, place the patient face up on a bed or on the floor.
2. Lift the lower extremities for 15 seconds.
3. Loosen the patient's collar.
4. Check the patient's pulse and blood pressure.
5. If consciousness does not return immediately, extend the patient's neck, etc.
(See the section on CPR, Chapter 2).
The text is divided into three sections: "Cardiac Emergency Syndromes" (syncope,
arrest, arrhythmias, and so on), "Apparatus Used in Treatment" (pacers, defibrilla-
tors, monitors, and the like), and "Drugs Used for Treatment." Thechapter on cardiac
arrest begins with a description of CPR. Regarding mouth-to-mouth breathing, the
author suggests placing a clean gauze or handkerchief over the patient's mouth as
prophylaxis against tuberculosis, hepatitis, and AIDS. Clearly, no one sophisticated
enough to read this book would provide rescue breathing to anyone but family
members. There is no mention ofcommonly used one-way mouth-to-mask equipment.
The author's description of how to determine the correct placement of esophageal
obturators refers to a model that is no longer used, and this information is not helpful
in evaluating the placement of current models. Obturators function poorly and are
presently used only in remote and rural areas not served by paramedics.
In the same chapter, some established ACLS algorithms are reproduced as figures
but not specifically discussed in the text. Instead, the steps for "definitive therapy" of
cardiac arrest are:
1. Start two IV infusions.
2. Treat hypotension with dopamine.
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3. Consider bicarbonate.
4. Defibrillation.
with the admonition to deliver the shocks during expiration!
The next subsection, "Treatment of Ventricular Fibrillation," starts with "If
lidocaine and DC shockare not effective in restoring sinus rhythm, 1 mg ofpropranolol
can be given .... " This statement is the first mention of lidocaine, and I wonder if
some paragraphs wereinadvertently deleted in preparing the newprinting plates. Also,
propranolol is absolutely not the second-line drug to employ. Epinephrine, the major
drug of choice for fibrillation unresponsive to shock, is first mentioned in the text two
pages later, under the heading "Intratracheal Injections." In this section an unfortu-
nate typographical error refers to "intratracheal" as "intrathecal." While the body of
the text correctly states that defibrillation should start at 200 watt seconds with
stepwise increase to 360, theaccompanying figure illustrates a firstdefibrillation at 400
watt seconds.
In the chapter on cardiogenic shock, there are repeated references to phentolamine
and metaraminol-agents no longer used in this context. The final sentence of the
section "Alpha Adrenergic Stimulating Drugs" states that these drugs are not recom-
mended for treatment ofcardiogenic shock; the same sentence was present in the third
and presumably the fourth edition. The author mentions phenoxybenzamine and then
states that the drug is no longer available. Why not delete all this useless information?
Forfluid resuscitation ofcardiogenicshock, theauthor suggests plasma, isotonicsaline,
or dextran 40. Plasma would be used only under conditions of an associated hypopro-
teinemia, and dextran 40 is no longer used for any purpose.
The chapter on supraventricular tachyarrhythmias still includes tensilon, neostig-
mine, phenylephrine, and metaraminol in the list of agents useful in converting these
dysrhythmias. These are drugs which have long since been replaced by more effective
agents.
Under "Thrombolysis" in the chapter on acute myocardial infarction, tissue plas-
minogen activator (TPA) is described in two short paragraphs. The final section ofthe
book, which contains an alphabetical listing and description ofdrugs useful in treating
cardiac emergencies, discusses digoxin for six pages, while TPA is not even mentioned.
A figure in thechapter on acutedissecting thoracic aortic aneurysmdescribes a 15-day
courseofmedicaltreatment inwhichsequential trimethaphan, reserpine, andguanethi-
dine are used, yet the text specifically states that nitroprusside is the first drug of
choice. Trimethaphan, reserpine, and guanethidine have been replaced by more
effective drugs for control of hypertension. This material is another of many sections
carried over from older editions that should have been culled.
Thevalue ofchapters on pacing would beenhanced iftheauthor added discussion on
pacer malfunction. Generally, the indications for pacer requirement are clear, and the
use of temporary pacers, either external or transcutaneous, usually do not present
much of a problem. It is pacer malfunction, not function that generates cardiac
emergencies. There is much to learn about failure to capture, failure to sense,
oversensing, and so on, which is not described. Also, in the category of "hardware,"
there is no mention of prosthetic valves or implantable automatic defibrillators and
their malfunctions.
Many references are 25 or more years old and are of historical interest only. A
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bibliography that is either annotated or referenced directly by the text would be
preferable.
I do not recommend this book as a guide to the treatment ofcardiac emergencies.
SAUL LANDE
Department ofEmergency Medicine
St. Joseph Medical Center
Stamford, Connecticut
INTERVENTIONAL CARDIOLOGY: FUTURE DIRECTIONS. Edited by John H.K. Vogel and
Spencer B. King III. St. Louis, MO, The C.V. Mosby Company, 1989. 527 pp. No
price.
In 1978, after first being refined in patients with peripheral vascular disease, the
technique of angioplasty was applied to coronary vessels. Since that time, the field of
interventional cardiology has virtually exploded. Angioplasty now enjoys widespread
acceptance, obviating the need for saphenous vein coronary bypass grafting in many
patients.
Catheter-based interventional techniques now are also being applied to the treat-
ment of valvular disease. While these procedures have eliminated the need for major
surgical procedures in some patients, they are not devoid ofmorbidity and mortality. It
is only now, after their use has become more widespread, that the complications that
may arise are being understood. Interventional Cardiology: Future Directions focuses
on the latest research and development in the field: laser angioplasty, balloon valvulo-
plasty, balloon angioplasty, and other mechanical devices for improving blood flow and
valvular and mechanical function.
The volume is divided into 40 chapters, and it has over 100 contributors. While this
large number of contributors adds to the depth of the text, it also, unfortunately,
detracts from thecohesiveness and readability ofthework. The individual chapters fail
to follow a consistent format. Both animal and human data are presented. Further-
more, the lackoforganization results in repetition. Each chapter is followed by a listof
references, which often duplicate references in the previous chapter. The format ofthe
chapters falls somewhere between a scientific paper and a textbook-style review article.
The book is loosely organized into sections such as angioscopy and laser techniques,
but there are no actual subheadings or section divisions. Most notably, basic introduc-
tory material is not included for the individual sections. Historical aspects are
interspersed throughout and are at times repetitive. Topics range from basic subjects
such as platelet aggregation to technical aspects of different catheter models. The
photographs and figures included are similarlyvaried. Thus, the major weakness ofthe
book is its lackofcohesiveness.
Despite these shortcomings, Interventional Cardiology: Future Directions does
represent a unique compilation ofstate-of-the-art experimental techniques in interven-
tional cardiology, and the authors have done a commendable job ofbringing together
work from an impressive scope of contributors. They do not specify the readership to
whom the work is addressed, but I suspect it is intended for an academic audience in
the field. The volume would also be of interest to medical students or physicians
interested in gaining an understanding ofsome ofthe newest interventional techniques
from a single source. Give the rapidity ofadvances in the field, however, it is likely that